🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking penalties, legal action or prison.

Service Response and Content Elimination

According to the social media company, the platform has removed problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one group, a seller posted contact information, where the majority of purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to possibly significant health risks”.